Cargando…

S100A8 in Serum, Urine, and Saliva as a Potential Biomarker for Systemic Lupus Erythematosus

OBJECTIVES: This study aimed to elucidate the potential of serum, urine, and saliva S100 calcium-binding protein A8 protein (S100A8) levels as biomarkers for systemic lupus erythematosus (SLE). METHODS: Serum, urine, and saliva samples were obtained from 249 patients with SLE from the Ajou lupus coh...

Descripción completa

Detalles Bibliográficos
Autores principales:	Kim, Ji-Won, Jung, Ju-Yang, Lee, Sang-Won, Baek, Wook-Young, Kim, Hyoun-Ah, Suh, Chang-Hee
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2022
Materias:	Immunology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9073082/ https://www.ncbi.nlm.nih.gov/pubmed/35529863 http://dx.doi.org/10.3389/fimmu.2022.886209

Ejemplares similares

Increased Immunoglobulin Gamma-3 Chain C in the Serum, Saliva, and Urine of Patients with Systemic Lupus Erythematosus
por: Jung, Ju-Yang, et al.
Publicado: (2023)

Polymorphisms of MFGE8 are associated with susceptibility and clinical manifestations through gene expression modulation in Koreans with systemic lupus erythematosus
por: Baek, Wook-Young, et al.
Publicado: (2019)

Sex hormones affect the pathogenesis and clinical characteristics of systemic lupus erythematosus
por: Kim, Ji-Won, et al.
Publicado: (2022)

Successful treatment of thrombotic thrombocytopenic purpura with plasmapheresis and anti-CD20 antibodies in a patient with immune thrombocytopenia and systemic lupus erythematosus: Case report
por: Jung, Ju-Yang, et al.
Publicado: (2022)

Associated clinical factors for serious infections in patients with systemic lupus erythematosus
por: Jung, Ju-Yang, et al.
Publicado: (2019)

Impact of Childbearing Decisions on Family Size of Korean Women with Systemic Lupus Erythematosus
por: Kim, In Je, et al.
Publicado: (2016)

Salivary Immunoglobulin Gamma-3 Chain C Is a Promising Noninvasive Biomarker for Systemic Lupus Erythematosus
por: Jung, Ju-Yang, et al.
Publicado: (2021)

Roles of Interactions Between Toll-Like Receptors and Their Endogenous Ligands in the Pathogenesis of Systemic Juvenile Idiopathic Arthritis and Adult-Onset Still’s Disease
por: Jung, Ju-Yang, et al.
Publicado: (2020)

Inflammatory markers in saliva and urine reflect disease activity in patients with systemic lupus erythematosus
por: Ruacho, Guillermo, et al.
Publicado: (2022)

Programmed Death-Ligand 1 Expression Potentiates the Immune Modulatory Function Of Myeloid-Derived Suppressor Cells in Systemic Lupus Erythematosus
por: Park, Min-Jung, et al.
Publicado: (2021)

Thrombocytopenia in Systemic Lupus Erythematosus: Clinical Manifestations, Treatment, and Prognosis in 230 Patients
por: Jung, Jin-Hee, et al.
Publicado: (2016)

Multicenter Retrospective Analysis of the Effectiveness and Safety of Rituximab in Korean Patients with Refractory Systemic Lupus Erythematosus
por: Bang, So-Young, et al.
Publicado: (2012)

Follicular Helper T Cells in Systemic Lupus Erythematosus
por: Kim, Sun Jung, et al.
Publicado: (2018)

Metabolic profiling reveals new serum signatures to discriminate lupus nephritis from systemic lupus erythematosus
por: Zhang, Yamei, et al.
Publicado: (2022)

Prevalence of osteoporosis in patients with systemic lupus erythematosus: A multicenter comparative study of the World Health Organization and fracture risk assessment tool criteria
por: Jung, Ju-Yang, et al.
Publicado: (2020)

Prevalence of Human Papilloma Virus Infections and Cervical Cytological Abnormalities among Korean Women with Systemic Lupus Erythematosus
por: Lee, You-Hyun, et al.
Publicado: (2010)

Three Clinical Clusters Identified through Hierarchical Cluster Analysis Using Initial Laboratory Findings in Korean Patients with Systemic Lupus Erythematosus
por: Jung, Ju-Yang, et al.
Publicado: (2022)

Elevated Salivary Alpha-Amylase Level, Association Between Depression and Disease Activity, and Stress as a Predictor of Disease Flare in Systemic Lupus Erythematosus: A Prospective Case–Control Study
por: Jung, Ju-Yang, et al.
Publicado: (2015)

Toll-like Receptor Signaling Inhibitory Peptide Improves Inflammation in Animal Model and Human Systemic Lupus Erythematosus
por: Baek, Wook-Young, et al.
Publicado: (2021)

Exploring urine:serum fractional excretion ratios as potential biomarkers for lupus nephritis
por: Soliman, Samar A., et al.
Publicado: (2022)

Intravenous Administration of Toll-Like Receptor Inhibitory Peptide 1 is Effective for the Treatment of Systemic Lupus Erythematosus in a Mus musculus Model
por: Baek, Wook-Young, et al.
Publicado: (2021)

Liver X receptors alpha gene (NR1H3) promoter polymorphisms are associated with systemic lupus erythematosus in Koreans
por: Jeon, Ja-Young, et al.
Publicado: (2014)

Glomerular Expression of S100A8 in Lupus Nephritis: An Integrated Bioinformatics Analysis
por: Qijiao, Wei, et al.
Publicado: (2022)

Urine and serum interleukin 35 as potential biomarkers of lupus nephritis
por: Nassif, Mary Atef
Publicado: (2021)

Infection in systemic lupus erythematosus, similarities, and differences with lupus flare
por: Jung, Ju-Yang, et al.
Publicado: (2017)

Analysis of Serum Interleukin (IL)-1β and IL-18 in Systemic Lupus Erythematosus
por: Mende, Rachel, et al.
Publicado: (2018)

T Helper 2-Associated Immunity in the Pathogenesis of Systemic Lupus Erythematosus
por: Ko, Haeun, et al.
Publicado: (2022)

Editorial: Focus on Systemic Lupus Erythematosus
por: Harris, James, et al.
Publicado: (2016)

HMGB1 in Systemic Lupus Erythematosus
por: Liu, Tianye, et al.
Publicado: (2020)

Elevated Serum Lysophosphatidylcholine in Patients with Systemic Lupus Erythematosus Impairs Phagocytosis of Necrotic Cells In Vitro
por: Grossmayer, Gerhard E., et al.
Publicado: (2018)

Serum Interleukin-26 Is a New Biomarker for Disease Activity Assessment in Systemic Lupus Erythematosus
por: Brilland, Benoit, et al.
Publicado: (2021)

A Systematic Review of the Progression of Cutaneous Lupus to Systemic Lupus Erythematosus
por: Curtiss, Paul, et al.
Publicado: (2022)

Absolute quantification and characterization of oxylipins in lupus nephritis and systemic lupus erythematosus
por: He, Jingquan, et al.
Publicado: (2022)

Baricitinib Attenuates Autoimmune Phenotype and Podocyte Injury in a Murine Model of Systemic Lupus Erythematosus
por: Lee, Jaeseon, et al.
Publicado: (2021)

Urine SERPINC1/ORM1 as biomarkers for early detection of lupus nephritis in MRL-lpr mice
por: Kim, Young-Eun, et al.
Publicado: (2023)

Breaking Immunological Tolerance in Systemic Lupus Erythematosus
por: Pieterse, Elmar, et al.
Publicado: (2014)

Mechanisms of Autoantibody Production in Systemic Lupus Erythematosus
por: Han, Shuhong, et al.
Publicado: (2015)

MIF: Implications in the Pathoetiology of Systemic Lupus Erythematosus
por: Lang, Tali, et al.
Publicado: (2015)

Editorial: Systemic Lupus Erythematosus and Antiphospholipid Syndrome
por: Meroni, Pier Luigi, et al.
Publicado: (2019)

Current Insights in Cutaneous Lupus Erythematosus Immunopathogenesis
por: Garelli, Colton J., et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_ch9ua97vh64j48fij7k1euv4is